Equities Analysts Issue Forecasts for NBIX Q4 Earnings
Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) – Equities research analysts at HC Wainwright lowered their Q4 2025 earnings estimates for Neurocrine Biosciences in a report issued on Friday, February 21st. HC Wainwright analyst A. Fein now expects that the company will post earnings per share of $1.06 for the quarter, down from their previous […]
Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) – Equities research analysts at HC Wainwright lowered their Q4 2025 earnings estimates for Neurocrine Biosciences in a report issued on Friday, February 21st. HC Wainwright analyst A. Fein now expects that the company will post earnings per share of $1.06 for the quarter, down from their previous […]
